Immune-related adverse events with adjuvant anti-PD-1 therapy in high-risk resected melanoma: a single-center experience - I. Csányi; C. Hánis; H. Ócsai; I. Németh; J. Oláh; R. Gyulai; E. Baltás (EJC Skin Cancer)